AB
TGTX icon

Amalgamated Bank’s TG Therapeutics TGTX Stock Holding History

Amalgamated Bank’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.97M Sell
35,779
-3,649
-9% -$149K 0.01% 843
2026
Q1 		$1.31M Sell
39,428
-294
-0.7% -$8.76K 0.01% 973
2025
Q4 		$1.18M Buy
39,722
+474
+1% +$15.5K 0.01% 1007
2025
Q3 		$1.42M Buy
39,248
+424
+1% +$14K 0.01% 938
2025
Q2 		$1.4M Buy
38,824
+501
+1% +$18.7K 0.01% 921
2025
Q1 		$1.51M Sell
38,323
-1,082
-3% -$36.4K 0.01% 884
2024
Q4 		$1.19M Sell
39,405
-123
-0.3% -$3.53K 0.01% 992
2024
Q3 		$925K Buy
39,528
+34,660
+712% +$757K 0.01% 1079
2024
Q2 		$87K Buy
4,868
+310
+7% +$4.95K ﹤0.01% 1741
2024
Q1 		$69K Sell
4,558
-15,241
-77% -$243K ﹤0.01% 1791
2023
Q4 		$338K Sell
19,799
-916
-4% -$10.6K ﹤0.01% 1593
2023
Q3 		$173K Hold
20,715
– – ﹤0.01% 1834
2023
Q2 		$515K Buy
20,715
+1,833
+10% +$47.3K ﹤0.01% 1425
2023
Q1 		$284K Sell
18,882
-2,316
-11% -$35.2K ﹤0.01% 1663
2022
Q4 		$251K Hold
21,198
– – ﹤0.01% 1770
2022
Q3 		$125K Buy
21,198
+340
+2% +$2.23K ﹤0.01% 2052
2022
Q2 		$89K Sell
20,858
-262
-1% -$1.64K ﹤0.01% 2213
2022
Q1 		$201K Sell
21,120
-1,602
-7% -$18.5K ﹤0.01% 1939
2021
Q4 		$432K Sell
22,722
-81
-0.4% -$2.1K ﹤0.01% 1655
2021
Q3 		$759K Sell
22,803
-1,403
-6% -$43.4K 0.01% 1385
2021
Q2 		$939K Buy
24,206
+7,982
+49% +$313K 0.01% 1318
2021
Q1 		$782K Sell
16,224
-612
-4% -$29.4K 0.03% 723
2020
Q4 		$876K Buy
16,836
+693
+4% +$23.4K 0.03% 630
2020
Q3 		$432K Buy
16,143
+1,722
+12% +$39.6K 0.02% 917
2020
Q2 		$281K Sell
14,421
-145
-1% -$2.33K 0.01% 1142
2020
Q1 		$143K Sell
14,566
-729
-5% -$9.21K ﹤0.01% 1439
2019
Q4 		$170K Buy
15,295
+1,633
+12% +$12.4K ﹤0.01% 1674
2019
Q3 		$77K Sell
13,662
-107
-0.8% -$746 ﹤0.01% 1676
2019
Q2 		$119K Buy
+13,769
New +$104K ﹤0.01% 1675

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Amalgamated Bank's TGTX Position: Q2 2026 in Review

Amalgamated Bank reduced its TG Therapeutics (TGTX) stake by 9.3% in Q2 2026, selling an estimated $149K and leaving 35,779 shares worth $1.97M. The position accounts for 0.01% of the portfolio, ranked #843.

Amalgamated Bank first reported a position in TGTX in Q2 2019 and has held it in 29 quarters since. 205 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Amalgamated Bank held 35,779 shares of TG Therapeutics worth $1.97M as of Q2 2026.
  • Amalgamated Bank sold 3,649 TG Therapeutics shares in Q2 2026, an estimated $149K.
  • TG Therapeutics made up 0.01% of Amalgamated Bank's portfolio in Q2 2026, its #843 holding.
  • Amalgamated Bank first reported a position in TG Therapeutics in Q2 2019 and has held it in 29 quarters since.
  • 205 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.